Chemed (NYSE:CHE) Price Target Raised to $625.00
Chemed (NYSE:CHE – Free Report) had its target price upped by Oppenheimer from $590.00 to $625.00 in a research report sent to investors on Wednesday, Benzinga reports. They currently have an outperform rating on the stock. CHE has been the subject of several other reports. Royal Bank of Canada boosted their price objective on Chemed […]
More Stories
Impax Asset Management Group (LON:IPX) Sets New 12-Month Low – Here’s What Happened
Impax Asset Management Group Plc (LON:IPX – Get Free Report)’s share price hit a new 52-week low during trading on...
Biglari (NYSE:BH.A) Shares Down 7% – Time to Sell?
Biglari Holdings Inc (NYSE:BH.A – Get Free Report)’s share price dropped 7% on Tuesday . The company traded as low...
Claros Mortgage Trust (NYSE:CMTG) Reaches New 52-Week Low – Here’s Why
Shares of Claros Mortgage Trust, Inc. (NYSE:CMTG – Get Free Report) reached a new 52-week low during trading on Tuesday...
Roku (NASDAQ:ROKU) Trading Down 0.4% – Time to Sell?
Roku, Inc. (NASDAQ:ROKU – Get Free Report) fell 0.4% on Tuesday . The stock traded as low as $78.01 and...
Fast Retailing (OTCMKTS:FRCOY) Announces Quarterly Earnings Results
Fast Retailing (OTCMKTS:FRCOY – Get Free Report) posted its quarterly earnings results on Thursday. The company reported $0.29 earnings per...
Trigon Metals (CVE:TM) Sets New 12-Month Low – Here’s What Happened
Trigon Metals Inc. (CVE:TM – Get Free Report)’s share price hit a new 52-week low on Thursday . The company...